ArticleJNCI cancer spectrum2026

Revisiting the impact of BRCA1 pathogenic variants on the aggressiveness of prostate cancer.

Hajime Sasagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.